Role of calcium in the constriction of isolated cerebral arteries
Description
Calcium entry blockers (CEB) have been used in the experimental treatment or prevention of many cerebrovascular disorders including stroke, post-ischemic hypoperfusion after cardiac arrest, cerebral vasospasm after subarachnoid hemorrhage, and migraine headache. However, the mechanism of action of these drugs on the cerebral circulation is poorly understood. This study examined the effects of calcium antagonists, Ca2+-deficient solutions, and vasocostrictors on cerebrovascular tone and 45Ca fluxes, to determine the role of calcium in cerebral arterial constriction. A Scatchard plot of 45Ca binding to BMCA showed that Ca2+ was bound at either low or high affinity binding sties. The four vasoconstrictors (potassium, serotonin, PGF/sub 2 α/, or SQ-26,655) each increased low affinity 45Ca uptake into BMCA. The results demonstrate that: (1) Potassium and serotonin constrict BMCA mainly by promoting Ca2+ influx through CEB-sensitive channels; (2) PGF/sub 2 α/ and SQ-26,655 constrict BMCA in part by promoting Ca2+ influx through CEB-sensitive channels, and in part by releasing Ca2+ from depletable internal stores; (3) The major action of CEB on BMCA is to block vasoconstrictor-induced Ca2+ uptake through both potential-operated (K+-stimulated) and receptor-operated channels
Availability note (English)
University Microfilms Order No. 87-16,494.Additional details
Publishing Information
- Imprint Pagination
- 203 p.
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 19092439
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Resource subtype / Literary indicator
- Thesis, Non-conventional Literature
- Descriptors DEI
- ARTERIES; BIOCHEMISTRY; CALCIUM COMPOUNDS; CALCIUM 45; CATTLE; CEREBRUM; PHYSIOLOGY; POTASSIUM COMPOUNDS; PROSTAGLANDINS; SEROTONIN; UPTAKE; VASOCONSTRICTION; VASOCONSTRICTORS
- Descriptors DEC
- ALKALI METAL COMPOUNDS; ALKALINE EARTH METAL COMPOUNDS; AMINES; ANIMALS; AUTONOMIC NERVOUS SYSTEM AGENT; AZOLES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BLOOD VESSELS; BODY; BRAIN; CALCIUM ISOTOPES; CARDIOVASCULAR AGENTS; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CHEMISTRY; DAYS LIVING RADIOISOTOPES; DOMESTIC ANIMALS; DRUGS; EVEN-ODD NUCLEI; HETEROCYCLIC COMPOUNDS; HYDROXY COMPOUNDS; INDOLES; INTERMEDIATE MASS NUCLEI; ISOTOPES; MAMMALS; NERVOUS SYSTEM; NEUROREGULATORS; NUCLEI; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PYRROLES; RADIOISOTOPES; RADIOPROTECTIVE SUBSTANCES; RESPONSE MODIFYING FACTORS; RUMINANTS; SYMPATHOMIMETICS; TRYPTAMINES; VERTEBRATES